| Product NDC: | 0075-2912 |
| Proprietary Name: | Lovenox |
| Non Proprietary Name: | enoxaparin sodium |
| Active Ingredient(s): | 120 mg/.8mL & nbsp; enoxaparin sodium |
| Administration Route(s): | INTRAVENOUS; SUBCUTANEOUS |
| Dosage Form(s): | INJECTION |
| Coding System: | National Drug Codes(NDC) |
| Product NDC: | 0075-2912 |
| Labeler Name: | sanofi-aventis U.S. LLC |
| Product Type: | HUMAN PRESCRIPTION DRUG |
| FDA Application Number: | NDA020164 |
| Marketing Category: | NDA |
| Start Marketing Date: | 19930329 |
| Package NDC: | 0075-2912-01 |
| Package Description: | 10 SYRINGE in 1 CARTON (0075-2912-01) > .8 mL in 1 SYRINGE |
| NDC Code | 0075-2912-01 |
| Proprietary Name | Lovenox |
| Package Description | 10 SYRINGE in 1 CARTON (0075-2912-01) > .8 mL in 1 SYRINGE |
| Product NDC | 0075-2912 |
| Product Type Name | HUMAN PRESCRIPTION DRUG |
| Non Proprietary Name | enoxaparin sodium |
| Dosage Form Name | INJECTION |
| Route Name | INTRAVENOUS; SUBCUTANEOUS |
| Start Marketing Date | 19930329 |
| Marketing Category Name | NDA |
| Labeler Name | sanofi-aventis U.S. LLC |
| Substance Name | ENOXAPARIN SODIUM |
| Strength Number | 120 |
| Strength Unit | mg/.8mL |
| Pharmaceutical Classes | Heparin, Low-Molecular-Weight [Chemical/Ingredient],Low Molecular Weight Heparin [EPC] |